Collegium Announces the Appointment of Joseph Ciaffoni as Chief Operating Officer by Carolyn Helms | May 30, 2017 | Portfolio News
Akebia Therapeutics Names Rita Jain, M.D. as Chief Medical Officer by Carolyn Helms | May 25, 2017 | Portfolio News
Akebia Initiates Phase 2 FO2RWARD Study of Vadadustat in Dialysis Patients with Anemia Related to Chronic Kidney Disease Hyporesponsive to Treatment with Erythropoiesis-Stimulating Agents by Carolyn Helms | May 24, 2017 | Portfolio News
ALPHAEON Submits Biologics License Application for DWP-450 Neuromodulator BLA Submitted within Three Years of First Patient Enrollment by Carolyn Helms | May 16, 2017 | Portfolio News
Akebia and Vifor Pharma Announce Exclusive License Agreement to Provide Vadadustat to Fresenius Medical Care in the U.S. Upon FDA Approval by Carolyn Helms | May 15, 2017 | Portfolio News
